Previous close | 29.12 |
Open | 29.19 |
Bid | 29.12 x 200 |
Ask | 29.35 x 200 |
Day's range | 28.82 - 29.42 |
52-week range | 19.80 - 35.50 |
Volume | |
Avg. volume | 849,547 |
Market cap | 1.643B |
Beta (5Y monthly) | 0.84 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Agios Pharmaceuticals stock had its Relative Strength (RS) Rating upgraded from 84 to 91 Monday. When looking for the best stocks to buy and watch, keep a close on eye on relative price strength. Is Agios Pharmaceuticals Stock A Buy?
Agios Pharmaceuticals shows rising price performance, earning an upgrade to its IBD Relative Strength Rating from 65 to 84.
Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) Q4 2023 Earnings Call Transcript February 15, 2024 Agios Pharmaceuticals, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good morning. And welcome to the Agios Fourth Quarter 2023 Earnings Conference Call. At this time, all […]